Lataa...
An Overview of Bimekizumab for the Treatment of Psoriatic Arthritis: The Evidence so Far
Psoriatic arthritis is a complex and heterogeneous disease with potential significant disability and impaired quality of life. Although in the last decades new treatment options have led to a better management of this disease, there are still significant unmet therapeutic needs. Dual inhibitor antib...
Tallennettuna:
| Julkaisussa: | Drug Des Devel Ther |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7955739/ https://ncbi.nlm.nih.gov/pubmed/33727793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S267405 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|